Search results
Trending tickers: Apple, Coinbase, Anglo American and Diageo
Yahoo Finance UK· 9 hours agoAmerica and the Caribbean. “Diageo’s weak share price performance has, in part, reflected questions...
Starbucks CFO says there are no plans to lower prices, but Wall Street is skeptical of its 2024...
Yahoo Finance· 2 days agoNow, it aims to regain customers with various tactics like value offerings, menu innovation, and...
Paramount has spent a decade as the source of buyout rumors. That might finally come to an end.
Yahoo Finance· 21 hours ago(Disclosure: Yahoo Finance is owned by Apollo.) Paramount's fate ultimately comes down to what...
Exclusive: Stanford AI leader Fei-Fei Li building 'spatial intelligence' startup
Reuters· 1 hour agoProminent computer scientist Fei-Fei Li is building a startup that uses human-like processing of...
11 fabulous farmhouses for rural bliss
Yahoo Finance UK· 13 hours agoThe principal buildings were constructed in the 1840s by John Knight, an agricultural pioneer who had bought the entire Exmoor Forest from The Crown....
Mondelez CEO keeps it real on inflation as earnings trounce estimates
Yahoo Finance· 3 days agoThe climb keeps getting steeper for the Oreo maker. "The inflationary environment is not easing at...
Starbucks CFO addresses prices & drop in sales as analysts say 'we're concerned'
The US Sun· 1 day agoSTARBUCKS is reeling as it desperately attempts to win back customers after undergoing a concerning...
3 Reliable and 1 Risky, Ultra High-Yield Dividend ETFs To Boost Your Passive Income Game
Benzinga via Yahoo Finance· 1 day agoFor income-focused investors, dividend ETFs can be an attractive option for generating steady cash...
Coinbase first quarter profits surged above $1 billion on ETF frenzy
Yahoo Finance· 9 hours agoAnd Coinbase has its own regulatory troubles. The firm is facing a 2023 lawsuit from the SEC...
Novo Nordisk sales up 26% driven by GLP-1s, misses 11% on Wegovy
AOL· 1 day agoNovo Nordisk (NVO) stock was trading down Thursday despite strong first quarter results, beating Wall Street consensus, led by the blockbuster GLP-1s Ozempic for diabetes and Wegovy for weight ...
